Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

67
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
67
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

514
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
514
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

844
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
844
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.

Transplantation proceedings·2009
Same author

Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients?

Anaesthesia and intensive care·2009
Same author

Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation.

Pharmacological research·2007
Same author

Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients.

Transplantation proceedings·2005
Same author

Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Urinary pharmacokinetics and theoretical pharmacodynamics of intravenous levofloxacin in intensive care unit patients treated with 500 mg b.i.d. for ventilator-associated pneumonia.

Journal of chemotherapy (Florence, Italy)·2004
Same journal

Breath alcohol concentrations in Japanese outpatients following paclitaxel and docetaxel infusion.

International journal of clinical pharmacology research·2006
Same journal

Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.

International journal of clinical pharmacology research·2006
Same journal

The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.

International journal of clinical pharmacology research·2006
Same journal

Evaluation of cytokine serum levels in patients with plaque-type psoriasis.

International journal of clinical pharmacology research·2006
Same journal

Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.

International journal of clinical pharmacology research·2006
Same journal

Etanercept for psoriasis: two case reports.

International journal of clinical pharmacology research·2006
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K

Primidone-carbamazepine interaction: clinical consequences.

P Benetello, M Furlanut

    International Journal of Clinical Pharmacology Research
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Primidone (PR) may reduce carbamazepine (CBZ) effectiveness in treating partial complex seizures. Stopping PR increased CBZ levels and improved seizure control, suggesting a drug interaction.

    More Related Videos

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
    10:44

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

    Published on: May 15, 2019

    13.9K
    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
    06:58

    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

    Published on: June 25, 2016

    20.1K

    Related Experiment Videos

    Last Updated: Feb 23, 2026

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
    07:35

    Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

    Published on: July 8, 2025

    1.4K
    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
    10:44

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

    Published on: May 15, 2019

    13.9K
    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
    06:58

    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

    Published on: June 25, 2016

    20.1K

    Area of Science:

    • * Pharmacology and Neurology
    • * Epilepsy treatment and drug interactions

    Background:

    • * A 15-year-old male patient presented with partial complex seizures, inadequately controlled by standard doses of primidone (PR) and carbamazepine (CBZ).
    • * Serum levels of carbamazepine were notably low, indicating potential pharmacokinetic interference.

    Observation:

    • * Seizure control significantly improved upon gradual discontinuation of primidone therapy.
    • * Cessation of primidone led to a marked increase in serum carbamazepine concentrations.

    Findings:

    • * Stopping primidone resulted in a substantial rise in carbamazepine serum levels.
    • * Carbamazepine-10, 11-epoxide levels decreased, and total carbamazepine clearance was reduced by 60%.
    • * This suggests primidone significantly enhances carbamazepine clearance.

    Implications:

    • * Clinicians should consider potential interactions between primidone and carbamazepine in epilepsy management.
    • * Monitoring serum drug levels is crucial when co-prescribing these antiepileptic drugs.
    • * Primidone may necessitate dose adjustments of carbamazepine to achieve therapeutic efficacy.